Artemisia genepi

Artemisia genepi acts primarily through its bitter sesquiterpenes and flavonoids. These compounds stimulate bitter receptors on the tongue, triggering a vagus nerve reflex that increases the secretion of gastric acid, bile, and pancreatic enzymes. This mechanism enhances appetite and improves the digestion of fats and proteins, while the essential oils provide antimicrobial benefits. Evidence Level: C/Traditional.

No, Artemisia genepi is considered unsafe during pregnancy and breastfeeding. The herb contains thujone, a compound known to stimulate uterine contractions, which may lead to miscarriage or premature labor. Thujone is also a neurotoxin that poses risks to fetal development. Women attempting to conceive should also avoid this herb. Evidence Level: C.

The traditional adult dosage for Artemisia genepi is 1-2 grams of dried herb prepared as an infusion (tea), taken shortly before meals to stimulate digestion. In the context of Alpine liqueurs, consumption is typically limited to small servings. Exceeding these amounts increases the risk of thujone toxicity and adverse effects. Evidence Level: C/Traditional.

Yes, Artemisia genepi carries significant interaction risks. Due to its thujone content, it may lower the seizure threshold, potentially counteracting anticonvulsant medications like phenytoin or valproate. It may also potentiate the effects of CNS depressants, such as alcohol, benzodiazepines, and barbiturates. Those on anticoagulants should use caution due to potential additive effects. Evidence Level: C/Theoretical.

When consumed in moderation as a liqueur, side effects are generally minimal. However, excessive consumption can cause gastrointestinal irritation, nausea, and vomiting. Due to the thujone and camphor content, high doses may lead to central nervous system effects, including dizziness, anxiety, restlessness, or headaches. Individuals with epilepsy should avoid it entirely due to seizure risk. Evidence Level: C.